On June 2, 2025, TuHURA Biosciences, Inc. entered into a securities purchase agreement to issue 4.76 million shares and warrants for about $12.6 million, aimed at funding a merger with Kineta, Inc. and clinical trials.
AI Assistant
TUHURA BIOSCIENCES INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.